Trial intelligence / Profile preview

Single vs Double Umbilical Cord Blood Transplantation in Pediatric High-Risk Leukemia and Myelodysplasia

NCT00412360Phase 3Completed

Sponsor
Medical College of Wisconsin
Start
Dec 2006
Primary completion
Mar 2014
Modality
Hematopoietic Stem Cells
Countries
3
01

Overview

Phase 3, randomised, open-label trial of umbilical cord blood in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML) and 2 more, sponsored by Medical College of Wisconsin. Started Dec 2006; status: completed.

02

Drugs

umbilical cord blood
03

Conditions

acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)myelodysplastic syndrome (MDS)Natural killer cell lymphoblastic leukemia/lymphoma (NK-LBL)

Beyond the preview

Go deeper on NCT00412360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00412360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call